Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-12-501967
Filing Date
2012-12-13
Accepted
2012-12-13 17:28:30
Documents
15
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d409799d10k.htm 10-K 1244296
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM d409799dex231.htm EX-23.1 1755
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d409799dex311.htm EX-31.1 9773
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d409799dex312.htm EX-31.2 10053
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 d409799dex321.htm EX-32.1 3917
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 d409799dex322.htm EX-32.2 3755
7 NUEDEXTA SAFETY INFORMATION d409799dex991.htm EX-99.1 2672
14 GRAPHIC g409799g31f84.jpg GRAPHIC 25184
15 GRAPHIC g409799g32m72.jpg GRAPHIC 60349
  Complete submission text file 0001193125-12-501967.txt   9976388

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT avnr-20120930.xml EX-101.INS 1370298
9 XBRL TAXONOMY EXTENSION SCHEMA avnr-20120930.xsd EX-101.SCH 89146
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avnr-20120930_cal.xml EX-101.CAL 76438
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE avnr-20120930_def.xml EX-101.DEF 313222
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE avnr-20120930_lab.xml EX-101.LAB 661989
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avnr-20120930_pre.xml EX-101.PRE 475870
Mailing Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656
Business Address 20 ENTERPRISE SUITE 200 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 001-15803 | Film No.: 121262937
SIC: 2834 Pharmaceutical Preparations